Sebode M - Search Results

1

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.

Steinmann S, Hartl J, Weidemann S, Füssel K, Kroll C, Sebode M, Lohse AW, Schramm C. Steinmann S, et al. Among authors: sebode m. JHEP Rep. 2023 Aug 29;5(12):100898. doi: 10.1016/j.jhepr.2023.100898. eCollection 2023 Dec. JHEP Rep. 2023. PMID: 37954487 Free PMC article.

2

Features and outcome of AIH patients without elevation of IgG.

Hartl J, Miquel R, Zachou K, Wong GW, Asghar A, Pape S, Sebode M, Peiseler M, Zenouzi R, Ehlken H, Krech T, Weiler-Normann C, Drenth JPH, Oo YH, Dalekos GN, Heneghan M, Schramm C, Lohse AW. Hartl J, et al. Among authors: sebode m. JHEP Rep. 2020 Feb 29;2(3):100094. doi: 10.1016/j.jhepr.2020.100094. eCollection 2020 Jun. JHEP Rep. 2020. PMID: 32280942 Free PMC article.

3

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.

Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, Baron U, Olek S, Wiegard C, Lohse AW, Weiler-Normann C, Schramm C, Herkel J. Peiseler M, et al. Among authors: sebode m. J Hepatol. 2012 Jul;57(1):125-32. doi: 10.1016/j.jhep.2012.02.029. Epub 2012 Mar 14. J Hepatol. 2012. PMID: 22425700

4

[Inflammatory diseases with liver and joint involvement. A differential diagnostic challenge].

Sebode M, Schramm C, Lohse AW. Sebode M, et al. Internist (Berl). 2013 Apr;54(4):441-8. doi: 10.1007/s00108-012-3191-6. Internist (Berl). 2013. PMID: 23455625 German.

5

Autoimmune hepatitis 2013 and beyond.

Weiler-Normann C, Sebode M, Lohse AW. Weiler-Normann C, et al. Among authors: sebode m. Minerva Gastroenterol Dietol. 2013 Jun;59(2):133-41. Minerva Gastroenterol Dietol. 2013. PMID: 23831905

6

Future perspective: immunomodulatory therapy for autoimmune hepatitis.

Sebode M, Lohse AW. Sebode M, et al. Dig Dis. 2014;32(5):502-6. doi: 10.1159/000360493. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034282 Review.

7

Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis.

Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse AW, Schramm C. Hartl J, et al. Among authors: sebode m. J Hepatol. 2015 Mar;62(3):642-6. doi: 10.1016/j.jhep.2014.10.018. Epub 2014 Oct 18. J Hepatol. 2015. PMID: 25457202

8

Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis.

Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hübener S, Pannicke N, Weiler-Normann C, Quaas A, Lohse AW, Schramm C. Hartl J, et al. Among authors: sebode m. J Hepatol. 2016 Oct;65(4):769-775. doi: 10.1016/j.jhep.2016.05.023. Epub 2016 May 26. J Hepatol. 2016. PMID: 27238753

9

Anti-TNF-α for necrotizing sarcoid granulomatosis of the liver.

Sebode M, Weidemann S, Wehmeyer M, Lohse AW, Schramm C. Sebode M, et al. Hepatology. 2017 Apr;65(4):1410-1412. doi: 10.1002/hep.28966. Epub 2017 Feb 3. Hepatology. 2017. PMID: 27981598

10

Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis.

Peiseler M, Liebscher T, Sebode M, Zenouzi R, Hartl J, Ehlken H, Pannicke N, Weiler-Normann C, Lohse AW, Schramm C. Peiseler M, et al. Among authors: sebode m. Clin Gastroenterol Hepatol. 2018 Feb;16(2):260-267.e1. doi: 10.1016/j.cgh.2016.12.040. Epub 2017 Jan 23. Clin Gastroenterol Hepatol. 2018. PMID: 28126427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page